Antibiotic Therapy for Spontaneous Bacterial Peritonitis

Treatment of Acute SBP

• The European Association for the Study of the Liver (EASL) recommends third-generation cephalosporins, specifically cefotaxime (2g IV every 8-12 hours) or ceftriaxone (1-2g IV every 12-24 hours), as the first-line empirical antibiotics for community-acquired SBP, which should be started immediately upon diagnosis 1, 2, 3
• For community-acquired SBP, cefotaxime 2g IV every 8-12 hours (4g/day is as effective as 8g/day) for 5-7 days achieves infection resolution rates of 77-98% 1, 2
• The American Association for the Study of Liver Diseases (AASLD) suggests that nosocomial or healthcare-associated SBP requires broader-spectrum coverage with meropenem (1g IV every 8 hours) plus daptomycin (6mg/kg/day) in settings with high multidrug-resistant organism (MDRO) prevalence, which is critical for patients in ICU, recent hospitalization, or septic shock 3

Alternative Antibiotic Options

• Amoxicillin/clavulanic acid (1g/0.2g IV every 8 hours, then switch to 0.5g/0.125g PO every 8 hours) achieves an 87% resolution rate, similar to cefotaxime 1, 4
• Oral ofloxacin (400mg PO every 12 hours) for uncomplicated SBP only achieves 84% infection resolution, comparable to IV cefotaxime 1, 4, 2

Essential Adjunctive Therapy

• The addition of IV albumin (1.5g/kg at diagnosis, then 1g/kg on day 3) to antibiotic therapy reduces hepatorenal syndrome from 30% to 10% and mortality from 29% to 10% 1, 4, 5, 6

Monitoring Treatment Response

• Repeat paracentesis at 48 hours to assess neutrophil count is recommended 1, 4, 2, 5
• Treatment failure is suspected if ascitic neutrophil count fails to decrease to <25% of pre-treatment value 1, 4, 2

Prevention of SBP

• The EASL recommends indefinite long-term antibiotic prophylaxis with norfloxacin 400mg PO daily for all patients surviving an SBP episode, which reduces SBP recurrence from 68% to 20% 6
• Local resistance patterns should guide prophylaxis choice 5

Key Clinical Pitfalls

• Never delay antibiotics waiting for culture results—empirical therapy must start immediately upon diagnosis 1, 2, 3
• Avoid aminoglycosides (e.g., tobramycin) due to nephrotoxicity 2
• Recognize the MDRO shift—nosocomial SBP now has 35% MDRO rate, requiring broader initial coverage 3
• Antibiotic stewardship—narrow coverage once cultures available and treat for shortest effective duration 3

Oral Antibiotics for Spontaneous Bacterial Peritonitis (SBP) Treatment

Initial Treatment Approach

• The American Association for the Study of Liver Diseases (AASLD) guidelines recommend that IV antibiotics should be started empirically in all patients with an ascites polymorphonuclear neutrophil (PMN) count >250/mm³ 7
• Oral ciprofloxacin (500 mg every 12 hours for 5-7 days) can be used for uncomplicated community-acquired SBP in clinically stable patients, or as step-down therapy after 2 days of IV ciprofloxacin 7

Critical Criteria for Oral Therapy

• Oral antibiotics should only be considered in patients who meet all of the following criteria: community-acquired SBP, clinically stable without sepsis or septic shock, no recent broad-spectrum antibiotic exposure, uncomplicated presentation, and not on quinolone prophylaxis 7

Essential Adjunctive Therapy

• IV albumin is mandatory: 1.5 g/kg at diagnosis, then 1.0 g/kg on day 3, which reduces hepatorenal syndrome from 30% to 10% and mortality from 29% to 10% 7, 8

Monitoring Requirements

• Repeat paracentesis at 48 hours to confirm PMN count decrease >25% from baseline, and if PMN fails to decrease adequately, broaden antibiotic coverage and investigate secondary peritonitis 7

Secondary Prophylaxis After SBP

• Oral ciprofloxacin 500 mg daily is a reasonable alternative to norfloxacin for indefinite prophylaxis, which reduces 1-year SBP recurrence from 68% to 20% 7, 8

Empirical Management of Community‑Acquired Spontaneous Bacterial Peritonitis with Septic Shock

First‑Line Antimicrobial Choice

• Cefotaxime 2 g IV every 8 hours is the gold‑standard empirical therapy for community‑acquired SBP presenting with septic shock, achieving infection‑resolution rates of 77 %–98 %. 9

Dosing Frequency

• A total daily dose of 4 g (2 g every 12 hours) is clinically equivalent to an 8 g/day regimen, but the every‑8‑hour schedule provides more consistent antimicrobial coverage in the setting of septic shock. 9

Treatment Duration

• The recommended course for uncomplicated SBP is 5–7 days; a 5‑day regimen is sufficient when an adequate clinical response is observed. 9

Contraindicated Empirical Agents

• Aminoglycosides (e.g., tobramycin, gentamicin) should not be used empirically in cirrhotic patients because they are nephrotoxic and less effective than cefotaxime. 9
• Quinolones (e.g., ciprofloxacin, ofloxacin) are contraindicated as first‑line agents in septic shock due to risks in severe presentations such as shock, renal impairment, hepatic encephalopathy, or gastrointestinal bleeding. 9

Timing of Antibiotic Initiation

• Empirical antibiotics must be administered immediately; delaying therapy while awaiting culture results is not acceptable. 9